RIVOGLITAZONE

UNII:	3A3N0634Q6
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₁₉N₃O₄S
Preferred Substance Name:	RIVOGLITAZONE
InChIKey:	XMSXOLDPMGMWTH-UHFFFAOYSA-N
GSRS Full Record:	3A3N0634Q6 i

185428-18-6
(±)-5-(P-((6-METHOXY-1-METHYL-2-BENZIMIDAZOLYL)METHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE
2,4-THIAZOLIDINEDIONE, 5-((4-((6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YL)METHOXY)PHENYL)METHYL)-
5-(4-(6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YLMETHOXY)BENZYL)THIAZOLIDIN-2,4-DIONE
5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
CS-011
DE-101
R 106056
R-106056
RIVOGLITAZONE [USAN]
Rivoglitazone [WHO-DD]
rivoglitazone [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RIVOGLITAZONE

Synonyms and Mappings

Resources